MedPath

A prospective cohort study of hypofractionated radiotherapy using 60Gy in 20 fractions for prostate cancer with IMRT/IGRT

Not Applicable
Recruiting
Conditions
prostate cancer
Registration Number
JPRN-UMIN000035606
Lead Sponsor
Iwate medical university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

1) Treated with brachytherapy 2) Received anti-androgen therapy for more than 1 year 3) After radical prostatectomy 4) Inflammatory bowel disease 5) Bilateral total hip arthroplasty 6) Synchronous or metachronous malignancies 7) Patients who attending physicians consider to be inappropriate due to other reasons mentioned above

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Five-year biochemical relapse-free survival
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath